Dexcom | DXCM - 当期純利益

株価
57.55
毎日の変更
-1.77 -2.98%
毎月
-7.03%
毎年
-19.38%
Q2 予測
60.25




当期純利益 変化する 日付
Abbott USD 1.08B 699M 2026-03
Align Technology USD 135.76M 79.01M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
J&J USD 5.24B 119M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Roche Holding CHF 5.47B 1.76B 2025-12
Solventum Corp USD 63M 1.2B 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
West Pharmaceutical Services USD 138.8M 6.7M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03